Cargando…

Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder

The prognostic value of squamous differentiation (SD) in urothelial carcinoma (UC) of the bladder is unclear. The aim of this study was to identify the clinical significance of SD in UC in terms of oncological outcomes in patients undergoing radical cystectomy (RC). We evaluated consecutive patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minato, Akinori, Noguchi, Hirotsugu, Tomisaki, Ikko, Fukuda, Atsushi, Kubo, Tatsuhiko, Nakayama, Toshiyuki, Fujimoto, Naohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144505/ https://www.ncbi.nlm.nih.gov/pubmed/30213195 http://dx.doi.org/10.1177/1073274818800269

Ejemplares similares

Premature Mortality Due to Malignancies of the Kidney and Bladder in Japan, 1980–2010
por: Pham, Truong-Minh, et al.
Publicado: (2019)

Treatment Strategies for Metastatic Castration-Sensitive Prostate Cancer: From “All-Comers” to “Personalized” Approach
por: Harada, Kenichi, et al.
Publicado: (2021)

An Effective Case for Chyluria by Retroperitoneoscopic Lymphatic Disconnection
por: Tomisaki, Ikko, et al.
Publicado: (2016)

Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Tomisaki, Ikko
Publicado: (2019)

A Case of Urinary Bladder Urothelial Carcinoma with Squamous, Glandular, and Plasmacytoid Differentiation
por: Makise, Naohiro, et al.
Publicado: (2014)

Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor
por: Harada, Mirii, et al.
Publicado: (2023)

Primary retroperitoneal mucinous cystadenocarcinoma with transition from the mesothelium
por: Tomisaki, Ikko, et al.
Publicado: (2020)

Editorial Comment to Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium laser enucleation of the prostate
por: Tomisaki, Ikko
Publicado: (2022)

Editorial Comment to A conservative treatment for eosinophilic cystitis
por: Tomisaki, Ikko
Publicado: (2022)

Macrophage CCL22 expression promotes lymphangiogenesis in patients with tongue squamous cell carcinoma via IL-4/STAT6 in the tumor microenvironment
por: Kimura, Satoshi, et al.
Publicado: (2021)

Comparative study of conventional urothelial carcinoma, squamous differentiation carcinoma and pure squamous carcinoma in patients with invasive bladder tumors
por: Gluck, G, et al.
Publicado: (2014)

Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy
por: Li, Gang, et al.
Publicado: (2017)

The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab
por: Furubayashi, Nobuki, et al.
Publicado: (2021)

Squamous cell and urothelial carcinomas in an ileal neobladder
por: Fujimoto, Takeru, et al.
Publicado: (2022)

Poor prognostic value of lymphovascular invasion for pT1 urothelial carcinoma with squamous differentiation in bladder cancer
por: Li, Gang, et al.
Publicado: (2016)

Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival
por: Li, Gang, et al.
Publicado: (2017)

Solitary cardiac metastasis of urothelial carcinoma of the urinary bladder with squamous cell differentiation – a rare manifestation
por: Duwe, Gregor, et al.
Publicado: (2023)

Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma
por: Wang, Yi-Fan, et al.
Publicado: (2023)

The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status
por: Furubayashi, Nobuki, et al.
Publicado: (2022)

Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs
por: Male, Musa, et al.
Publicado: (2019)

Sarcomatoid Urothelial Carcinoma of the Urinary Bladder With Chondrosarcomatous and Concurrent Divergent Squamous Cell Carcinoma Differentiation– A Rare Entity
por: Kumar Pal, Atanu, et al.
Publicado: (2022)

Outcomes of poorly differentiated and plasmacytoid variant bladder urothelial carcinoma
por: Lockhart, Kathleen, et al.
Publicado: (2021)

Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab
por: Furubayashi, Nobuki, et al.
Publicado: (2022)

Significant Correlation between Chromosomal Aberration and Nuclear Morphology in Urothelial Carcinoma
por: Shuto, Masayo, et al.
Publicado: (2012)

Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2017)

Mandibular Metastasis of a Recurrent Poorly Differentiated Urothelial Bladder Carcinoma
por: Aoun, Georges, et al.
Publicado: (2020)

AB130. The expression and clinical significance of HIF-1α in bladder urothelial carcinoma
por: Fan, Haitao
Publicado: (2016)

Angiogenesis related gene expression significantly associated with the prognostic role of an urothelial bladder carcinoma
por: Wang, Jianfeng, et al.
Publicado: (2020)

Gelsolin, an Actin-Binding Protein: Bioinformatic Analysis and Functional Significance in Urothelial Bladder Carcinoma
por: Alsofyani, Abeer A., et al.
Publicado: (2023)

Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder
por: Okubo, Kazuki, et al.
Publicado: (2020)

The Association between Metabolic Syndrome and High-Stage Primary Urothelial Carcinoma of the Bladder
por: Nagase, Kei, et al.
Publicado: (2018)

Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder
por: Kim, Donghyun, et al.
Publicado: (2020)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Role of angiogenesis in urothelial bladder carcinoma
por: Fus, Łukasz Piotr, et al.
Publicado: (2016)

Bladder melanosis with concurrent urothelial carcinoma
por: Yau, Susanna E., et al.
Publicado: (2017)

Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019)

Giant Cell Urothelial Carcinoma of Bladder
por: Wijesinghe, Harshima Disvini, et al.
Publicado: (2021)

Molecular classification of urothelial bladder carcinoma
por: Schwarzova, Lucia, et al.
Publicado: (2023)

AB176. Impact of squamous and/or glandular differentiation on recurrence and progression after transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2016)

Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder
por: Kim, Hyung Suk, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c4k7lokkh1ss32aaq02qgj32g5